Dependence receptors and cancer: Addiction to trophic ligands

Cancer Research

Volumn 75, Issue 24, 2015, Pages 5171-5175

  Gibert, Benjamin ^a   Mehlen, Patrick ^a  

^a UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DELETED IN COLORECTAL CARCINOMA PROTEIN; DEPENDENCE RECEPTOR; DOXORUBICIN; FLUOROURACIL; MEMBRANE RECEPTOR; NEOGENIN; NETRIN 1; NEUROTROPHIN 3 RECEPTOR; NEUROTROPHIN RECEPTOR; PACLITAXEL; PLEXIN; PLEXIND1; PROTEIN PATCHED; SONIC HEDGEHOG PROTEIN; UNC5H RECEPTOR; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; LIGAND;

ANTIANGIOGENIC ACTIVITY; APOPTOSIS; AUTOCRINE EFFECT; CANCER PROGNOSIS; CANCER RISK; CARCINOGENESIS; COLORECTAL CANCER; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; LOSS OF FUNCTION MUTATION; METASTASIS; NEUROBLASTOMA; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; ANIMAL; METABOLISM; NEOPLASM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; HUMANS; LIGANDS; NEOPLASMS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION;

EID: 84955252610     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-14-3652     Document Type: Review

References (46)

1. Bredesen DE, Mehlen P, Rabizadeh S. Receptors that mediate cellular dependence. Cell Death Differ 2005; 12: 1031-43.
2. Rabizadeh S,Oh J, Zhong LT, Yang J, Bitler CM, Butcher LL, et al. Induction of apoptosis by the low-affinity NGF receptor. Science 1993; 261: 345-8.
3. Goldschneider D, Mehlen P. Dependence receptors: A new paradigm in cell signaling and cancer therapy. Oncogene 2010; 29: 1865-82.
4. Luchino J, Hocine M, Amoureux MC, Gibert B, Bernet A, Royet A, et al. Semaphorin 3E suppresses tumor cell death triggered by the plexin D1 dependence receptor in metastatic breast cancers. Cancer Cell 2013; 24: 673-85.
5. Boucher J,Macotela Y, Bezy O, Mori MA, Kriauciunas K, Kahn CR. A kinaseindependent role for unoccupied insulin and IGF-1 receptors in the control of apoptosis. Sci Signal 2010; 3: Ra87.
6. Delloye-Bourgeois C, Gibert B, Rama N, Delcros JG, Gadot N, Scoazec JY, et al. Sonic Hedgehog promotes tumor cell survival by inhibiting CDON pro-apoptotic activity. PLoS Biol 2013; 11: E1001623.
7. Mehlen P, Rabizadeh S, Snipas SJ, Assa-Munt N, Salvesen GS, Bredesen DE. The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis. Nature 1998; 395: 801-4.
8. Mehlen P, Tauszig-Delamasure S. Dependence receptors and colorectal cancer. Gut 2014; 63: 1821-9.
9. Castets M, Broutier L, Molin Y, Brevet M, Chazot G, Gadot N, et al. DCC constrains tumour progression via its dependence receptor activity. Nature 2012; 482: 534-7.
10. Krimpenfort P, Song JY, ProostN, Zevenhoven J, Jonkers J, Berns A.Deleted in colorectal carcinoma suppresses metastasis in p53-deficient mammary tumours. Nature 2012; 482: 538-41.
11. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-67.
12. Bernet A, Mazelin L, Coissieux MM, Gadot N, Ackerman SL, Scoazec JY, et al. Inactivation of the UNC5C Netrin-1 receptor is associated with tumor progression in colorectal malignancies. Gastroenterology 2007; 133: 1840-8.
13. Genevois AL, Ichim G, CoissieuxMM,Lambert MP, Lavial F,Goldschneider D, et al. Dependence receptor TrkC is a putative colon cancer tumor suppressor. Proc Natl Acad Sci U S A 2013; 110: 3017-22.
14. Thiebault K, Mazelin L, Pays L, Llambi F, Joly MO, Saurin JC, et al. The netrin-1 receptors UNC5H are putative tumor suppressors controlling cell death commitment. Proc Natl Acad Sci U S A 2003; 100: 4173-78.
15. Shin SK, Nagasaka T, Jung BH, Matsubara N, Kim WH, Carethers JM, et al. Epigenetic and genetic alterations in Netrin-1 receptors UNC5C and DCC in human colon cancer. Gastroenterology 2007; 133: 1849-57.
16. Luo Y, Kaz AM, Kanngurn S, Welsch P, Morris SM, Wang J, et al. NTRK3 is a potential tumor suppressor gene commonly inactivated by epigenetic mechanisms in colorectal cancer. PLoS Genet 2013; 9: E1003552.
17. Gibert B, Delloye-Bourgeois C, Gattolliat CH, Meurette O, Le Guernevel S, Fombonne J, et al. Regulation by miR181 family of the dependence receptorCDONtumor suppressive activity in neuroblastoma. J Natl Cancer Inst 2014; 106.
18. Krauthammer M, Kong Y, Ha BH, Evans P, Bacchiocchi A, McCusker JP, et al. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet 2012; 44: 1006-14.
19. CoissieuxMM, Tomsic J, Castets M,Hampel H, Tuupanen S, Andrieu N, et al. Variants in the netrin-1 receptor UNC5C prevent apoptosis and increase risk of familial colorectal cancer. Gastroenterology 2012; 141: 2039-46.
20. Kury S,GarrecC,Airaud F, Breheret F, Guibert V, Frenard C, et al. Evaluation of the colorectal cancer risk conferred by rare UNC5C alleles. World J Gastroenterol 2014; 20: 204-13.
21. Thibert C, Teillet MA, Lapointe F, Mazelin L, LeDouarin NM, Mehlen P. Inhibition of neuroepithelial patched-induced apoptosis by sonic hedgehog. Science 2003; 301: 843-6.
22. Mille F, Thibert C, Fombonne J, Rama N, Guix C, Hayashi H, et al. The Patched dependence receptor triggers apoptosis through a DRAL-caspase-9 complex. Nat Cell Biol 2009; 11: 739-46.
23. Fombonne J, Bissey PA, Guix C, Sadoul R, Thibert C, Mehlen P. Patched dependence receptor triggers apoptosis through ubiquitination of caspase- 9. Proc Natl Acad Sci U S A 2012; 109: 10510-5.
24. Bardelli A, Corso S, Bertotti A, Hobor S, Valtorta E, Siravegna G, et al. Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancer. Cancer Discov 2013; 3: 658-73.
25. Zhang J, Yang PL, Gray NS. Targeting cancer with small-molecule kinase inhibitors. Nat Rev Cancer 2009; 9: 28-39.
26. Mehlen P. Dependence receptors: The trophic theory revisited. Sci Signal 2010; 3: Pe47.
27. Llambi F, Lourenco FC, Gozuacik D, Guix C, Pays L, Del Rio G, et al. The dependence receptor UNC5H2 mediates apoptosis through DAP-kinase. EMBO J 2005; 24: 1192-201.
28. Guenebeaud C, Goldschneider D, Castets M, Guix C, Chazot G, Delloye- Bourgeois C, et al. The dependence receptor UNC5H2/B triggers apoptosis via PP2A-mediated dephosphorylation of DAP kinase. Mol Cell 2010; 40: 863-76.
29. Gozuacik D, Kimchi A. DAPk protein family and cancer. Autophagy 2006; 2: 74-9.
30. Forcet C, Stein E, Pays L, Corset V, Llambi F, Tessier-Lavigne M, et al. Netrin- 1-mediated axon outgrowth requires deleted in colorectal cancer-dependent MAPK activation. Nature 2002; 417: 443-7.
31. Ming GL, Wong ST, Henley J, Yuan XB, Song HJ, Spitzer NC, et al. Adaptation in the chemotactic guidance of nerve growth cones. Nature 2002; 417: 411-8.
32. Mehlen P, Delloye-Bourgeois C, Chedotal A. Novel roles for Slits and netrins: Axon guidance cues as anticancer targets? Nat Rev Cancer 2011; 11: 188-97.
33. Akino T, Han X, Nakayama H, McNeish B, Zurakowski D, Mammoto A, et al. Netrin-1 promotes medulloblastoma cell invasiveness and angiogenesis, and demonstrates elevated expression in tumor tissue and urine of patients with pediatric medulloblastoma. Cancer Res 2014; 74: 3716-26.
34. Fitamant J, Guenebeaud C, Coissieux MM, Guix C, Treilleux I, Scoazec JY, et al. Netrin-1 expression confers a selective advantage for tumor cell survival in metastatic breast cancer. Proc Natl Acad Sci U S A 2008; 105: 4850-5.
35. Harter PN, Zinke J, Scholz A, Tichy J, Zachskorn C, Kvasnicka HM, et al. Netrin-1 expression is an independent prognostic factor for poor patient survival in brain metastases. PLoS ONE 2014; 9: E92311.
36. Mazelin L, Bernet A, Bonod-Bidaud C, Pays L, Arnaud S, Gespach C, et al. Netrin-1 controls colorectal tumorigenesis by regulating apoptosis. Nature 2004; 431: 80-4.
37. Paradisi A, Creveaux M, Gibert B, Devailly G, Redoulez E, Neves D, et al. Combining chemotherapeutic agents and netrin-1 interference potentiates cancer cell death. EMBO Mol Med 2013; 5: 1821-34.
38. Qi Q, Li DY, Luo HR, Guan KL, Ye K. Netrin-1 exerts oncogenic activities through enhancing Yes-associated protein stability. Proc Natl Acad Sci U S A 2015; 112: 7255-60.
39. Bouzas-Rodriguez J, Cabrera JR,Delloye-Bourgeois C, Ichim G, Delcros JG, Raquin MA, et al. Neurotrophin-3 production promotes human neuroblastoma cell survival by inhibiting TrkC-induced apoptosis. J Clin Invest 2010; 120: 850-8.
40. Rubin LL, de Sauvage FJ. Targeting the Hedgehog pathway in cancer. Nat Rev Drug Discov 2006; 5: 1026-33.
41. Wilson BD, Ii M, Park KW, Suli A, Sorensen LK, Larrieu-Lahargue F, et al. Netrins promote developmental and therapeutic angiogenesis. Science 2006; 313: 640-4.
42. Larrivee B, Freitas C, Trombe M, Lv X, Delafarge B, Yuan L, et al. Activation of the UNC5B receptor by Netrin-1 inhibits sprouting angiogenesis. Genes Dev 2007; 21: 2433-47.
43. Castets M, Coissieux MM, Delloye-Bourgeois C, Bernard L, Delcros JG, Bernet A, et al. Inhibition of endothelial cell apoptosis by netrin-1 during angiogenesis. Dev Cell 2009; 16: 614-20.
44. Chinchilla P, Xiao L, Kazanietz MG, Riobo NA. Hedgehog proteins activate pro-angiogenic responses in endothelial cells through non-canonical signaling pathways. Cell Cycle 2010; 9: 570-79.
45. Ozmadenci D, Feraud O, Markossian S, Kress E, Ducarouge B, Gibert B, et al. Netrin-1 regulates somatic cell reprogramming and pluripotency maintenance. Nat Commun 2015; 6: 7398.
46. Mehlen P, PuisieuxA.Metastasis: A question of life or death. Nat Rev Cancer 2006; 6: 449-58.